Ken Griffin Good Rx Holdings, Inc. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$6.5 - $8.91 $227,500 - $311,850	35,000 Added 44.08%	114,400 $892,000
Q1 2024 May 15, 2024	SELL	$5.37 - $8.35 $515,520 - $801,600	-96,000 Reduced 54.73%	79,400 $563,000
Q4 2023 Feb 14, 2024	SELL	$4.44 - $6.7 $199,356 - $300,830	-44,900 Reduced 20.38%	175,400 $1.18 Million
Q3 2023 Nov 14, 2023	BUY	$5.23 - $9.24 $250,517 - $442,596	47,900 Added 27.78%	220,300 $1.24 Million
Q2 2023 Aug 14, 2023	BUY	$4.36 - $6.2 $3,924 - $5,580	900 Added 0.52%	172,400 $951,000
Q1 2023 May 15, 2023	SELL	$4.71 - $6.66 $704,145 - $995,670	-149,500 Reduced 46.57%	171,500 $1.07 Million
Q4 2022 Feb 14, 2023	SELL	$4.06 - $5.71 $177,827 - $250,098	-43,800 Reduced 12.01%	321,000 $1.5 Million
Q3 2022 Nov 14, 2022	SELL	$4.67 - $7.81 $311,956 - $521,708	-66,800 Reduced 15.48%	364,800 $1.7 Million

182

131M

696K

657K

Ticker GDRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 84,394,800
Market Cap $598M
Description
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.